Actemra (Tocilizumab) Infusion Cost in 2026, and How to Lower It
A single Actemra (tocilizumab) IV infusion runs about $3,500 to $7,000 for the drug, and a full hospital-billed visit is often $4,500 to $9,000 or more. Because Actemra is a Genentech drug, if you qualify the Genentech Patient Foundation can provide it free, and where you infuse can cut the bill in half.
- Actemra IV is dosed by weight (4 to 8 mg/kg, usually every 4 weeks) and billed under J-code J3262, so your drug cost scales with your dose.
- Site of care is the biggest lever. A standalone infusion center or doctor’s office is often 40 to 60% cheaper than a hospital outpatient department for the same infusion.
- Genentech makes Actemra, so uninsured or underinsured patients under an income limit may get it free through the Genentech Patient Foundation, which does not require citizenship information.
What an Actemra Infusion Costs
These are national estimates for the IV form. Your bill depends on your weight-based dose, the site of care, and your plan.
| Where you get it | Typical billed cost per infusion |
|---|---|
| Hospital outpatient department | ~$6,000 to $12,000 |
| Infusion center / doctor’s office | ~$4,500 to $9,000 |
| Subcutaneous (self-inject) option | no infusion facility fee |
| With the Genentech Patient Foundation | as low as $0 (drug) |
Tocilizumab biosimilars (such as Tofidence and Tyenne) are also available and may cost less. Ask your prescriber and plan.
Already got a bill for your Actemra (tocilizumab) infusion? Check if you were overcharged.
A typical Actemra (tocilizumab) infusion runs $4,500 to $9,000 without insurance. Enter what you were charged and we will flag it.
Or send us the bill and we will fight it down. 64% of cases reduced.
How to Lower the Cost
Ask if the maker will provide it free
If you are uninsured, or insured but your plan will not cover it, and your income is under the limit, the Genentech Patient Foundation (1-888-941-3331) can provide Actemra free. Your prescriber submits the request and the drug ships to your infusion center. It does not require citizenship information.
Move the infusion to a lower-cost site
If you are stable, ask your prescriber whether your infusions can move from a hospital to an in-network infusion center or doctor’s office. It commonly cuts the bill by 40 to 60% for the identical drug and dose.
Match assistance to your coverage
Commercially insured? A Genentech copay card can reduce your coinsurance. On Medicare? Use an independent charity fund (PAN, HealthWell, Good Days) instead, since copay cards are not allowed. Our help paying for medication tool routes you to the right one.
Check the bill, starting with the J-code units
Actemra is billed per milligram (J3262), so a units or wastage error can multiply the charge. CareRoute Bill Defense checks the units, facility fees, and network status and disputes errors, with no fee unless we save you money.
Frequently Asked Questions
How much does an Actemra infusion cost?
The drug alone runs about $3,500 to $7,000 per IV infusion, and a full hospital-billed visit is often $4,500 to $9,000 or more. Because Actemra is dosed by weight, your exact cost depends on your dose, and a standalone infusion center is usually much cheaper than a hospital.
Can I get Actemra for free?
Possibly. Genentech makes Actemra, and the Genentech Patient Foundation provides it free to uninsured or underinsured patients under an income limit (generally up to about 500% of the federal poverty level, with hardship reviewed higher). Your prescriber submits the request, the drug ships to your infusion center, and the Foundation does not require citizenship information.
Is the infusion cheaper somewhere other than the hospital?
Usually, yes. A standalone infusion center or a doctor’s office is often 40 to 60% cheaper than a hospital outpatient department for the same Actemra infusion, because you avoid the hospital facility fee. If you are stable, ask your prescriber whether the infusion can be moved.
Is there a cheaper version of Actemra?
Tocilizumab biosimilars (such as Tofidence and Tyenne) are FDA-approved and may cost less than brand Actemra. There is also a subcutaneous (self-injected) form that avoids the infusion facility fee. Whether either is right for you is a decision for your prescriber.
I have insurance but the coinsurance is huge. What can I do?
With commercial insurance, a Genentech copay card can bring your coinsurance close to $0 up to an annual max. On Medicare, use an independent charity fund (PAN, HealthWell, Good Days) instead, since copay cards are not allowed. Either way, once you reach your out-of-pocket maximum, in-network covered care is paid at 100% for the rest of the year.
Related
Sources
- CMS Average Sales Price (ASP) drug pricing files (J3262 tocilizumab)
- Genentech Patient Foundation (free-drug eligibility and process)
- FDA (tocilizumab biosimilar approvals)
- Health Care Cost Institute and AHA (hospital facility fees and site-of-care differentials)
Prices are national estimates for 2026 and vary widely by dose, site, and plan. Any change of drug or infusion site is a decision for you and your prescriber. This page is educational and is not medical or financial advice. Last updated August 2026.